Connor, Clark & Lunn Investment Management (CC&L)
CCXI

Connor, Clark & Lunn Investment Management (CC&L)’s ChemoCentryx, Inc. CCXI Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-56,739
Closed -$772K – 1122
2018
Q1 		$772K Sell
56,739
-7,760
-12% -$80.1K ﹤0.01% 511
2017
Q4 		$384K Sell
64,499
-1,276
-2% -$8.75K ﹤0.01% 657
2017
Q3 		$488K Sell
65,775
-20,300
-24% -$169K ﹤0.01% 644
2017
Q2 		$806K Buy
86,075
+16,625
+24% +$122K 0.01% 532
2017
Q1 		$506K Buy
69,450
+24,975
+56% +$180K ﹤0.01% 627
2016
Q4 		$329K Buy
44,475
+16,775
+61% +$121K ﹤0.01% 699
2016
Q3 		$167K Buy
+27,700
New +$131K ﹤0.01% 749

Other funds holding CCXI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CCXI Position: Q2 2018 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of ChemoCentryx, Inc. (CCXI) in Q2 2018, closing a stake of 56,739 shares — an estimated $772K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CCXI in Q3 2016 and held it in 7 quarters. The position peaked at $806K in Q2 2017. 115 funds tracked by Wall St. Rank hold CCXI as of Q2 2018.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining ChemoCentryx, Inc. position as of Q2 2018 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 56,739 ChemoCentryx, Inc. shares in Q2 2018, an estimated $772K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in ChemoCentryx, Inc. in Q3 2016 and held it in 7 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ChemoCentryx, Inc. position peaked at $806K in Q2 2017.
  • 115 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2018.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2018, filed 2 Aug 2018.